Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Piperazine derivatives useful as CCR5 antagonists

US Patent 6391865 · Granted May 21, 2002

Estimated economic value: $155,179,000

Assignee

Inventors

View full patent text on Google Patents →